Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo

P.F. Sullivan, E.J.C. de Geus, G. Willemsen, M.R. James, J.H. Smit, T. Zandbelt, V. Arolt, B.T. Baune, D. Blackwood, S. Cichon, W.L. Coventry, K. Domschke, A. Farmer, M. Fava, S.D. Gordon, Q. He, A.C. Heath, P. Heutink, F. Holsboer, W.J.G. HoogendijkJ.J. Hottenga, Y. Hu, M. Kohli, D. Lin, S. Lucae, D.J. MacIntyre, W. Maier, K.A. McGhee, P. McGuffin, GW Montgomery, W.J. Muir, W.A. Nolen, M.M. Nöthen, R.H. Perlis, K. Pirlo, D. Posthuma, M. Rietschel, P. Rizzu, A. Schosser, A.B. Smit, J.W. Smoller, J.Y. Tzeng, R. van Dyck, M. Verhage, F. G. Zitman, N.G. Martin, N.R. Wray, D.I. Boomsma, B.W.J.H. Penninx

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Major depressive disorder (MDD) is a common complex trait with enormous public health significance. As part of the Genetic Association Information Network initiative of the US Foundation for the National Institutes of Health, we conducted a genome-wide association study of 435 291 single nucleotide polymorphisms (SNPs) genotyped in 1738 MDD cases and 1802 controls selected to be at low liability for MDD. Of the top 200, 11 signals localized to a 167 kb region overlapping the gene piccolo (PCLO, whose protein product localizes to the cytomatrix of the presynaptic active zone and is important in monoaminergic neurotransmission in the brain) with P-values of 7.7 × 10
Original languageEnglish
Pages (from-to)359-375
JournalMolecular Psychiatry
Volume14
Issue number4
DOIs
Publication statusPublished - 2009

    Fingerprint

Cite this